NCT05447546View on ClinicalTrials.gov

Study to Evaluate HT-6184 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

July 20, 2023

Study Completion Date

July 20, 2023

Conditions
Normal Healthy Subjects
Interventions
DRUG

HT-6184

Oral capsule

DRUG

HT-6184 Placebo

Oral capsule

Trial Locations (1)

07410

TKL Research, Inc., Fair Lawn

Sponsors
All Listed Sponsors
collaborator

TKL Research, Inc.

INDUSTRY

lead

Halia Therapeutics, Inc.

INDUSTRY